Bradley A. Keywell Sells 265,000 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) major shareholder Bradley A. Keywell sold 265,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was sold at an average price of $35.10, for a total value of $9,301,500.00. Following the transaction, the insider now owns 15,218,365 shares in the company, valued at $534,164,611.50. This trade represents a 1.71 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Tempus AI Price Performance

Shares of NASDAQ:TEM opened at $35.15 on Friday. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $79.49. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The company has a 50 day moving average of $46.03 and a 200-day moving average of $47.18.

Analyst Ratings Changes

TEM has been the subject of several research reports. Bank of America lifted their price target on shares of Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a report on Friday, December 13th. Guggenheim initiated coverage on Tempus AI in a research report on Monday, December 9th. They set a “buy” rating and a $74.00 price target on the stock. Needham & Company LLC restated a “buy” rating and set a $56.00 price objective on shares of Tempus AI in a research report on Tuesday, January 14th. Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and increased their target price for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Finally, Loop Capital reduced their price target on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a report on Tuesday, January 14th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Tempus AI presently has an average rating of “Moderate Buy” and a consensus price target of $56.36.

Hedge Funds Weigh In On Tempus AI

Several hedge funds have recently modified their holdings of TEM. First Horizon Advisors Inc. acquired a new position in Tempus AI during the third quarter worth about $30,000. FNY Investment Advisers LLC acquired a new position in shares of Tempus AI in the 4th quarter worth approximately $67,000. Vestor Capital LLC bought a new stake in shares of Tempus AI in the 3rd quarter worth approximately $153,000. Stifel Financial Corp acquired a new stake in Tempus AI during the third quarter valued at approximately $218,000. Finally, Sandia Investment Management LP bought a new stake in Tempus AI during the second quarter worth approximately $136,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.